Neurolymphomatosis - Rare presentation in non-hodgkin's lymphoma: The role of 18 F-fluorodeoxyglucose positron-emission tomography and computerized tomography imaging

Authors

Nosheen Fatima, Aga Khan UniversityFollow
Maseeh Uz Zaman, Aga Khan UniversityFollow
Areeba Zaman, Civil Hospital Karachi, Karachi, Pakistan
Sidra Uz Zaman, Dow University of Health Sciences, Karachi, Pakistan

Document Type

Report

Department

Radiology

Abstract

Neurolymphomatosis (NLS) is infiltration of lymphoma cells into the peripheral or cranial nervous system and is a rare manifestation of non-Hodgkin lymphoma (NHL). Nerve biopsy is considered as the gold standard for diagnosis but not a preferred choice, and magnetic resonance imaging has lower reported sensitivity. ¹⁸F-Fluorodeoxyglucose (¹⁸FDG) positron-emission tomography and computerized tomography (PET/CT) has a higher sensitivity for diagnosing and assessing the neurological and nonneurological metabolic tumor volume and response evaluation to therapy. We present the case of a lady, known to have NHL in remission. She presented with a short history of severe pain and weakness of the right lower limb. Baseline and interim ¹⁸FDG PET/CT played a crucial role in diagnosing and assessing the extent of NLS and nonneurological disease burden and also in evaluation of response to treatment.

Publication (Name of Journal)

World Journal of Nuclear Medicine

Recommended Citation

Fatima, N., Zaman, M. U., Zaman, A., Zaman, S. U. (2020). Neurolymphomatosis - Rare presentation in non-hodgkin's lymphoma: The role of 18 F-fluorodeoxyglucose positron-emission tomography and computerized tomography imaging. World Journal of Nuclear Medicine, 19(2), 159-161.
Available at: https://ecommons.aku.edu/pakistan_fhs_mc_radiol/467